Affordably Source Oncology Experts and Industry Participants for Market Research, Diligence and Projects

Submit an anonymous Project Description -- Start receiving responses within a few hours

Have a need? Explain it here






How Zintro Works

  1. 1. Provide a clear description of your needs and your expectations of an expert, consultant or job candidate and Zintro will match it with the most relevant professionals in our platform.
  2. 2. Within a day or two typically 6 - 12 Experts, who have opted-in, will contact you with a brief explanation of their qualifications and how they can help.
  3. 3. You can communicate back and forth, qualify each other, connect and pay fees to Experts through Zintro.
  4. Zintro is free, anonymous and without obligation.

Loved by Thousands

Loved by thousands logos

Need Help?A phone icon1-877-236-7016

Recent Oncology Inquiries

Area Icon

Emerging Technologies In Oncology

Our client is interested in speaking with oncology key opinion leaders to better understand the future changes in imaging procedures and care pathways or patient journey centric. Ideally, they are looking for leaders who can discuss the following technology segments: theranostics, personalized medicine (in-vitro diagnostics, genomics, proteomics, radiomics), and artificial intelligence. An incentive of $400 will be paid to participants for a 1-hour phone interview. Please provide a brief answer as to your relevance to the space below: do you work in the us or european healthcare setting where patients with cancers (oncology) are treated? Which best describes you? Physician (md) - medical oncologist physician (md) – surgical oncologist physician (md) – radiation oncologist clinical or organizational leadership - md (chief medical officer, chief innovation officer, cxo role) pathologist (md) certified physician assistant advanced practice registered nurse (nurse practitioner, clinical nurse specialist, etc.) registered nurse others (please specify) which of the following emerging technology areas are you familiar with in the context of oncology patient diagnostics and treatment? A. Theranostics – imaging-related area pairing diagnostic and therapeutic agents b. Artificial intelligence c. Personalized medicine (including in-vitro diagnostics, genomics, proteomics, radiomics) d. Diagnostic imaging - use of imaging modalities as part of patient diagnosis and care depending on cancer (e.G. Mri, ct, mammography, pet, spect, ixr, x-ray, ultrasound please discuss briefly the current or future perspective on theranostics, personalized medicine (in-vitro diagnostics, genomics, proteomics, radiomics), artificial intelligence areas in terms of pain points, realized market usage, and growth. *please note that we are only interested in your personal point of view and are not seeking confidential information. **referrals are highly appreciated

  1. Profile Picture

    Athanasios |Planning Officer at Department of Pharma

    I am interested in this position. I work on oncology landscape in European healthcare organization. ...

    13.4 Hours Later
  2. Profile Picture

    Alejandro D. |Vice President

    I am a medical oncologist (MD) with 21 years of experience. Most of my career has been in Clinical R...

    13.6 Hours Later
  3. Profile Picture

    Timothy |Director Of Research and Development

    I have over 20 years experience in oncology and previcion medicine, as well as immunooncology and th...

    13.7 Hours Later
+36 Other Responses
Area Icon

Pediatric Oncology

Us pediatric oncologists only we are currently working on a project trying to define the most effective treatment for acute lymphoblastic leukemia. We are looking for us pediatric oncologists experts that could provide us with their point of view on how this disease is currently treated and what are the major pros and cons of current products in use. Example questions: • how is all currently treated across the various patient segments (e.G., induction, consolidation, maintenance)? • what treatment protocols do you prefer and follow? • what are the major barriers for erwinaze use? Do you think you could be available on the 21, 22 or 23rd of march to schedule a time for this phone conversation? It would be of great help if you could suggest a couple of time slots when you would be available to schedule the phone conversation. Please do not hesitate to contact me should you have further questions. Thank you very much for your help and consideration. Best regards, maria

  1. Profile Picture

    Harvey |President

    Sounds like you are looking for an MD.....I used to manage a group doing COG research. I may be wil...

    5.7 Hours Later
  2. Profile Picture

    Hilde |PhD, medcial liaison, medcial advisor, b

    Dear Maria, I am a biomedical consultant that works independent. I could help you on this project ...

    13.1 Days Later
+2 Other Responses
Area Icon

Norwegian Market In Bladder Cancer

We are looking for participants who can speak on the market access landscape for bladder cancer therapies in norway. We are interested to speak with the following: - heor expert payers - healthcare providers (hematologists/oncologists/urologists) this is a 60-minutes paid phone interview. Please provide a brief answer as to your relevance to this space: for heor expert payers: 1. Please rate your level of expertise on the following topics on a scale of 1-5, where 1 represents low expertise and 5 represents industry-leading expertise: - national, regional or local hta assessments - risk-benefit and heor calculations - economic modeling & clinical trial review - pricing and reimbursement of adjuvant treatments in oncology 2. Have you ever advised national, regional, and/or local healthcare decision-making bodies in your market? Please briefly elaborate for healthcare providers: 1. Please rate your level of expertise on the following topics on a scale of 1-5, where 1 represents low expertise and 5 represents industry-leading expertise: - national, regional or local hta assessments - clinical trial design and clinical endpoint evaluation - patient sub-group analysis and patient population definition - muscle-invasive bladder cancer therapy selection - adjuvant therapy selection 2. Have you ever directly advised national, regional, and/or local healthcare decision-making bodies in your market? Please briefly elaborate.

  1. Profile Picture

    Eivid |Managing Director

    Rate: $250 Yes, I can help. I have been working with HE&MA for 20 years. I quite frequently have su...

    5.6 Hours Later
  2. Profile Picture

    Jan |Oncologist, Researcher

    rate: $250 Oslo Area, Norway I might be interested. FOR HEALTHCARE PROVIDERS: Have experience all...

    17.6 Hours Later
  3. Profile Picture

    Markus |First line sales manager

    Sorry, i have only knowledge of the german pharma / healthcare market...

    7.4 Days Later
+7 Other Responses
Area Icon

Oncology Finance

We are looking for partners in financing ongoing oncology project specialized on liposomal chemotherapy drugs - the first of which has been already granted orphan drug status by ema with ongoing registrational phase iv clinical trials in lung cancer

  1. Profile Picture

    Floyd |Chief Pathologist

    I have surpervised oncology clinical trials in the past (including an orphan drug trial) and now am ...

    2.9 Hours Later
  2. Profile Picture

    Len |Owner

    Are you looking for a financial partner or someone to manage the process?...

    2.1 Days Later
  3. Profile Picture

    Muhammad Zeeshan |Project Manager

    Hi i am a doctor working in oncology division of a pharma company. i can provide oncology *****...

    5.1 Days Later
+5 Other Responses
Area Icon

Lung Cancer Drug Market

We are looking to speak to experts about market access and pricing landscape for non-small cell lung carcinoma (nsclc) and the role/perception of immuno-oncology drugs within the landscape (e.G. Keytruda, opdivo, etc.). We are interested to speak to spanish regional pharmacy directors / regional payer. This would be for a 1-hour paid phone consult. Please respond with a few brief statements as to your relevance in this space. 1. Please rank your level of experience and insight on the following products used for nsclc treatment on a scale of 1 to 5 (1 = low, 5 = high). Please briefly elaborate. - opdivo: - keytrude: - tecentriq: - imfinzi: 2. Would you be able to review key value themes and provide thoughts on data points that would be most relevant to shape across decision-making within their market? Please briefly elaborate.

  1. Profile Picture

    Sonia |Medical Director

    Yes, I am interested. I could make myself available next Monday. Regards, Sonia...

    6.9 Hours Later
  2. Profile Picture

    Ignacio |Head of Department of Oncology

    Yes, I’d be interested and available during the next few days. I’m a medical oncologist specialized...

    3.9 Days Later
  3. Profile Picture

    José |Consultant Oncologist

    Yes, I am interested. Please find my answers below:- 1. Please rank your level of experience and i...

    6 Days Later
+5 Other Responses
Area Icon

Scientist Cancer Immunology

Responsibilities include: -design and perform research in target and validation -establish and run in vivo tumor models -develop and perform in vitro immunoassays including primary lymphocyte cultures, antibody characterization -stay abreast of latest scientific and technology advancements in the field -attend team meetings -deliver presentations education: -m.S. Degree with 10+ years or b.S. Degree with 15+ years in immunology -ph.D. With 2+ years ’postdoctoral training requirements: junior scientist level -extensive hands-on experience in basic immunology techniques including flow cytometry, cytokine analysis, cytotoxicity and proliferation assays -proficiency in designing and executing a variety of in vivo tumor models -previous experience in antibody drug discovery, a plus senior scientist level -faculty member in academia or principle scientist leading a drug discovery team -drug development experience and the ability to troubleshoot -strong vision in immuno-oncology with excellent publications record -management experience, a plus

  1. Profile Picture

    Denis |Expert in Flow Cytometry / Core Lab Head

    Dear Sirs My name is Denis Baev. By April, 2015 I worked as a Senior Postdoctoral Researcher in Bio...

    4 Hours Later
  2. Profile Picture

    Constantin |Zintro Expert

    Dear Sir/Ms: I am interested in your job in Cancer Immunology. My CV is published in Ikaroscancerva...

    19.1 Hours Later
  3. Profile Picture

    New |

    Shuwen Chen 8950 Costa Verde Blvd, 4321 | San Diego, CA ***** Tel: ***** | Email: lysw99@...

    1.6 Days Later
+26 Other Responses
Area Icon

Metastatic Pancreatic Cancer Therapy Market

We are looking for participants who can speak on the market access landscape for current and future metastatic pancreatic cancer therapies in germany. We are interested to speak with the following: - current or former regional / local payer; former national payer / consultant - kol stakeholders: ludwig-maximilians-universitat (lmu) munchen; joint practice for interdisciplinary oncology and hematology, freiburg this is a 60-minutes paid phone interview and a 90-minutes paid phone interview. Please provide a brief answer as to your relevance to this space: for payers: 1. How would you describe your current role? 2. Have you participated in any market research studies in the past month regarding metastatic pancreatic cancer? For kol stakeholders: 1. What is your primary specialty? 2. Approximately how many metastatic pancreatic cancer patients do you consult and/or treat on a monthly basis? 3. Please score your level of expertise and insight on the metastatic pancreatic cancer space from 1 to 5, where 1 is low and 5 is high. Please briefly elaborate. 4. Please score your ability to discuss the impact of clinical evidence packages on regulatory approval, access, and reimbursement in your market from 1 to 5, where 1 is low and 5 is high. Please briefly elaborate. 5. Please score your ability to review product profiles and provide thoughts on data points that would be most relevant to shape decision-making in your market from 1 to 5, where 1 is low and 5 is high. Please briefly elaborate. 6. Have you ever advised national, regional, and/or local healthcare decision-making bodies in your market? Please briefly elaborate.

  1. Profile Picture

    Werner |Head of MSL Oncology

    Rate: $250 1. What is your primary specialty? a. Oncology - Pharmaceutical Industry 2. Approximat...

    18 Hours Later
  2. Profile Picture

    Volker |European Life Science Accelerator/Pharma

    Yes, I am interested. 1. How would you describe your current role? - Consultant Pharma & Biotech 2...

    1.2 Days Later
  3. Profile Picture

    Hartmut |Medical Leader Benefit Assessment Cancer

    1. What is your primary specialty? Ans: Medical Affairs and benefit assessment in the pharmaceutica...

    1.4 Days Later
+14 Other Responses
Area Icon

Oncology Clinical Support Market

I am researching the oncology clinical decision support market.  i am looking for a health insurance employee who is responsible for improving diagnosis and treatment of cancer and for reducing cost of cancer care.  i want to learn the health insurance perspective of such a tool and any requirements or priorities that payers would like to see.

  1. Profile Picture

    Robert |Medical Director

    Sounds like a good it for my experience...

    2 Hours Later
  2. Profile Picture

    Brad |Consultant

    Hi, I have this ***** my work in the Oncology reimbursement area. ...

    3.8 Hours Later
  3. Profile Picture

    Vladimir |Zintro Expert

    Hello, I am MD Urologist, Ph.D., Professor of Oncological department in St.-Petersburg (Russia). Can...

    4.5 Hours Later
+11 Other Responses
Area Icon

Veterinary Oncologist - Stereotactic Radiosurgery

We are looking to speak with pet or veterinary oncologists that are familiar with stereotactic radiosurgery (srs), and can help us better understand this practice in relation to conventional radiation therapy. Ideally, we are looking to learn about the trends in pet oncology, consumer willingness to do procedures given pricing, cancer treatment options, and stereotactic radiosurgery in general. Please provide us with your experience within these areas, and your knowledge of the above. Thank you.

  1. Profile Picture

    Carl |Chief RadiationTherapist

    I am Chief *****apist at Advanced Oncology Center in West Covina, CA. I am familiar with SR...

    1.2 Hours Later
  2. Profile Picture

    Ramesh |Physician and President

    I have set up, managed as well as *****ral ***** SRS on a Cyberknife machine . We als...

    19 Hours Later
  3. Profile Picture

    Michael |Director, Clinical Studies Center

    I am a board-certified veterinary oncologist with 20+ years experience in *****ialty practic...

    3.7 Days Later
+6 Other Responses
Area Icon

Secondary-immunodeficiency In Blood Cancer

We would like to speak with physicians ( hematologist-oncologists, immunologists, and infectious disease specialists) involved in the diagnosis, treatment, and ongoing management of patients with sid that is associated with chronic lymphocytic leukemia (cll), multiple myeloma (mm), or non-hodgkin’s lymphoma (nhl). We are aiming to carry out message testing to identify messages that are most compelling to physicians with respect to the diagnosis and treatment of secondary immune deficiency (sid) associated with hematological cancers. This is a 75-minutes paid phone consultation and a 10 minutes pre-task. If open to participating, please provide a brief answer to the screener below: 1. Do you see at least 10 patients per month with secondary immunodeficiency (sid) associated with chronic lymphocytic leukemia (cll), multiple myeloma, or non-hodgkin’s lymphoma (nhl)? Please note that we are only interested in your personal point of view and are not seeking confidential information. Referrals are highly appreciated

  1. Profile Picture

    Mart |Marketing Director SPECT Europe

    Sorry no real *****, I'm not a physician and not in any way involved in ***** CLL. There...

    15 Hours Later
  2. Profile Picture

    VICTOR |Zintro Expert

    Thanks for asking for insights on this subject ***** confirm my availability for this consult...

    15.5 Hours Later
  3. Profile Picture

    Alessandro |Healthcare Manager

    I am not a physician but I have experience as biologist/***** payer....

    16.1 Hours Later
+6 Other Responses
Area Icon

Oncology

We have a client who is looking into how the oncology lab market works. They would like to speak with someone who can discuss reimbursement trends, patient volume trends, and technology trends within the industry. They would like to speak with someone who has experience managing oncology labs. This would be a 60 minute phone consultation.

  1. Profile Picture

    Rosalynn |Consultant

    I have 9 years experience managing a clinical diagnostics lab that specializes in oncology diagnosti...

    5 Minutes Later
  2. Profile Picture

    Rita |Principle

    Dear PI-COM-MR-LM, I can certianly help you with this project. As head of marketing, and working wi...

    44 Minutes Later
  3. Profile Picture

    Shyam |CFO Advisor

    Very knowledgeable about Oncology lab market given my experience with VOA among others and can discu...

    44 Minutes Later
+8 Other Responses
Area Icon

Healthcare Informatics - Oncology, Esrd

Assignment is on healthcare informatics product/solution offering for disease such as oncology, end stage renal disease, venous, peripheral artery disease, among others. Most of the product solution offering relates to cater the application areas such as population health management, revenue cycle management, precision medicine, radiology imaging, drug discovery, etc. Key objective is to understand the overall value these informatics products and solutions offer to their customers; both economical and clinical objective is to understand the following: 1. Overall value chain of the industry to understand: • key players operating at different level • how crowded is the domain (no of companies at different level) • data flow among various stakeholders such as payor, provider, government bodies, patients, research labs • which application type is highly dominated application (revenue cycle management, population health management, patient engagement, risk stratification, precision medicine, drug discovery, etc.) • key problems addressed by the product/solution offered in the industry • what are the current unmet needs, that needs to be addressed in near future 2. What economic and clinical value does this informatics solutions bring in for the customers – providers, payors, government, patients 3 trending technologies (other than ai, ml, big data, etc) in use for developing the informatics solutions for the above mentioned disease

  1. Profile Picture

    Neri |Lead Clinical Informatics Liaison

    Right in my wheelhouse at Lead Clinical *****son and Vice-Chair (Innovation, Information ...

    9.6 Hours Later
  2. Profile Picture

    Sara |Business Mentor

    The request is extremely specialized. I am only comfortable speaking about Oncology because I have ...

    9.8 Hours Later
  3. Profile Picture

    Praveen |Director

    Can provide lot of insights as Director of Clinical informatics...

    11 Hours Later
+44 Other Responses
See More Inquiries

the branch of medicine that studies tumors (cancer) and seeks to understand their development, diagnosis, treatment, and prevention

Top Oncology Experts

See More Experts
Share
LinkedInTwitterFacebookGoogle+